Literature DB >> 23233676

A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.

Brandon L Garcia1, Brady J Summers, Kasra X Ramyar, Apostolia Tzekou, Zhuoer Lin, Daniel Ricklin, John D Lambris, John H Laity, Brian V Geisbrecht.   

Abstract

Complement is a network of interacting circulatory and cell surface proteins that recognizes, marks, and facilitates clearance of microbial invaders. To evade complement attack, the pathogenic organism Staphylococcus aureus expresses a number of secreted proteins that interfere with activation and regulation of the complement cascade. Staphylococcal complement inhibitors (SCINs) are one important class of these immunomodulators and consist of three active members (SCIN-A/-B/-C). SCINs inhibit a critical enzymatic complex, the alternative pathway C3 convertase, by targeting a functional "hot spot" on the central opsonin of complement, C3b. Although N-terminal truncation mutants of SCINs retain complement inhibitory properties, they are significantly weaker binders of C3b. To provide a structural basis for this observation, we undertook a series of crystallographic and NMR dynamics studies on full-length SCINs. This work reveals that N-terminal SCIN domains are characterized by a conformationally dynamic helical motif. C3b binding and functional experiments further demonstrate that this sequence-divergent N-terminal region of SCINs is both functionally important and context-dependent. Finally, surface plasmon resonance data provide evidence for the formation of inhibitor·enzyme·substrate complexes ((SCIN·C3bBb)·C3). Similar to the (SCIN·C3bBb)(2) pseudodimeric complexes, ((SCIN·C3bBb)·C3) interferes with the interaction of complement receptors and C3b. This activity provides an additional mechanism by which SCIN couples convertase inhibition to direct blocking of phagocytosis. Together, these data suggest that tethering multi-host protein complexes by small modular bacterial inhibitors may be a global strategy of immune evasion used by S. aureus. The work presented here provides detailed structure-activity relationships and improves our understanding of how S. aureus circumvents human innate immunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23233676      PMCID: PMC3554951          DOI: 10.1074/jbc.M112.426858

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Authors:  Ilse Jongerius; Brandon L Garcia; Brian V Geisbrecht; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

2.  Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.

Authors:  Suzan H M Rooijakkers; Maartje Ruyken; Anja Roos; Mohamed R Daha; Julia S Presanis; Robert B Sim; Willem J B van Wamel; Kok P M van Kessel; Jos A G van Strijp
Journal:  Nat Immunol       Date:  2005-08-07       Impact factor: 25.606

3.  Dynamic alpha-helices: conformations that do not conform.

Authors:  Kuljeet Singh Sandhu; Debasis Dash
Journal:  Proteins       Date:  2007-07-01

Review 4.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

5.  Staphylococcal complement inhibitor: structure and active sites.

Authors:  Suzan H M Rooijakkers; Fin J Milder; Bart W Bardoel; Maartje Ruyken; Jos A G van Strijp; Piet Gros
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

6.  Structures of complement component C3 provide insights into the function and evolution of immunity.

Authors:  Bert J C Janssen; Eric G Huizinga; Hans C A Raaijmakers; Anja Roos; Mohamed R Daha; Kristina Nilsson-Ekdahl; Bo Nilsson; Piet Gros
Journal:  Nature       Date:  2005-09-22       Impact factor: 49.962

7.  Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b.

Authors:  Brandon L Garcia; Kasra X Ramyar; Apostolia Tzekou; Daniel Ricklin; William J McWhorter; John D Lambris; Brian V Geisbrecht
Journal:  J Mol Biol       Date:  2010-07-21       Impact factor: 5.469

8.  Diversity in the C3b [corrected] contact residues and tertiary structures of the staphylococcal complement inhibitor (SCIN) protein family.

Authors:  Brandon L Garcia; Brady J Summers; Zhuoer Lin; Kasra X Ramyar; Daniel Ricklin; Divya V Kamath; Zheng-Qing Fu; John D Lambris; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

9.  1H, 13C, and 15N NMR backbone assignments and secondary structure of human interferon-gamma.

Authors:  S Grzesiek; H Döbeli; R Gentz; G Garotta; A M Labhardt; A Bax
Journal:  Biochemistry       Date:  1992-09-08       Impact factor: 3.162

10.  A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.

Authors:  Daniel Ricklin; Apostolia Tzekou; Brandon L Garcia; Michal Hammel; William J McWhorter; Georgia Sfyroera; You-Qiang Wu; V Michael Holers; Andrew P Herbert; Paul N Barlow; Brian V Geisbrecht; John D Lambris
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

View more
  11 in total

1.  The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase.

Authors:  Jordan L Woehl; Daphne A C Stapels; Brandon L Garcia; Kasra X Ramyar; Andrew Keightley; Maartje Ruyken; Maria Syriga; Georgia Sfyroera; Alexander B Weber; Michal Zolkiewski; Daniel Ricklin; John D Lambris; Suzan H M Rooijakkers; Brian V Geisbrecht
Journal:  J Immunol       Date:  2014-11-07       Impact factor: 5.422

2.  Identification of C3b-Binding Small-Molecule Complement Inhibitors Using Cheminformatics.

Authors:  Brandon L Garcia; D Andrew Skaff; Arindam Chatterjee; Anders Hanning; John K Walker; Gerald J Wyckoff; Brian V Geisbrecht
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

3.  Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.

Authors:  Brady J Summers; Brandon L Garcia; Jordan L Woehl; Kasra X Ramyar; Xiaolan Yao; Brian V Geisbrecht
Journal:  Mol Immunol       Date:  2015-06-04       Impact factor: 4.407

4.  Expression, purification, and characterization of a human complement component C3 analog that lacks the C-terminal C345c domain.

Authors:  Kasra X Ramyar; Xin Xu; Natalie M White; Andrew Keightley; Brian V Geisbrecht
Journal:  J Immunol Methods       Date:  2019-07-15       Impact factor: 2.303

5.  gC1qR/C1qBP/HABP-1: Structural Analysis of the Trimeric Core Region, Interactions With a Novel Panel of Monoclonal Antibodies, and Their Influence on Binding to FXII.

Authors:  Ying Zhang; Alexander J Vontz; Ethan M Kallenberger; Xin Xu; Nicoleta T Ploscariu; Kasra X Ramyar; Brandon L Garcia; Berhane Ghebrehiwet; Brian V Geisbrecht
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

6.  Staphylococcus aureus genomic pattern and atopic dermatitis: may factors other than superantigens be involved?

Authors:  A Rojo; A Aguinaga; S Monecke; J R Yuste; G Gastaminza; A España
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-27       Impact factor: 3.267

7.  Group B Streptococcus Surface Protein β: Structural Characterization of a Complement Factor H-Binding Motif and Its Contribution to Immune Evasion.

Authors:  Xin Xu; Alexander L Lewis Marffy; Andrew Keightley; Alex J McCarthy; Brian V Geisbrecht
Journal:  J Immunol       Date:  2022-02-02       Impact factor: 5.422

8.  Structural basis of lantibiotic recognition by the nisin resistance protein from Streptococcus agalactiae.

Authors:  Sakshi Khosa; Benedikt Frieg; Daniel Mulnaes; Diana Kleinschrodt; Astrid Hoeppner; Holger Gohlke; Sander H J Smits
Journal:  Sci Rep       Date:  2016-01-04       Impact factor: 4.379

Review 9.  Novel Evasion Mechanisms of the Classical Complement Pathway.

Authors:  Brandon L Garcia; Seline A Zwarthoff; Suzan H M Rooijakkers; Brian V Geisbrecht
Journal:  J Immunol       Date:  2016-09-15       Impact factor: 5.422

10.  Identification of a staphylococcal complement inhibitor with broad host specificity in equid Staphylococcus aureus strains.

Authors:  Nienke W M de Jong; Manouk Vrieling; Brandon L Garcia; Gerrit Koop; Matt Brettmann; Piet C Aerts; Maartje Ruyken; Jos A G van Strijp; Mark Holmes; Ewan M Harrison; Brian V Geisbrecht; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2018-02-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.